- ￥593 - 3840
- Solarbio
- 北京
- IB2300
- 2026年01月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 保质期：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 英文名：
BAY-1217389
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- CAS号：
1554458-53-5
- 规格：
50mg/25mg/10mg/2mg/5mg
| 规格： | 50mg | 产品价格： | ￥3840.0 |
|---|---|---|---|
| 规格： | 25mg | 产品价格： | ￥2555.0 |
| 规格： | 10mg | 产品价格： | ￥1415.0 |
| 规格： | 2mg | 产品价格： | ￥593.0 |
| 规格： | 5mg | 产品价格： | ￥940.0 |
BAY 1217389选择性丝氨酸/苏氨酸激酶monopolar spindle 1 (Mps1)抑制剂。
| 基本信息 | |
| CAS | No.1554458-53-5 |
| 英文名称 | BAY-1217389 |
| 别名 | ;BAY-1217389;Imazapic;Imazameth;Imazapic，Pestana |
| 分子式 | C27H24F5N5O3 |
| 分子量 | 561.5 |
| 溶解性 | Soluble in DMSO |
| 纯度 | ≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| SMILES | O=C(NC1CC1)C2=CC=C(C3=CN=C4C(NCCC(F)(F)F)=CC(OC5=CC=C(OC)C(F)=C5F)=NN43)C=C2C |
| 靶点 | Mps1 |
| 通路 | Cell Cycle; Cytoskeleton |
| 背景说明 | BAY 1217389选择性丝氨酸/苏氨酸激酶monopolar spindle 1 (Mps1)抑制剂。 |
| 生物活性 | BAY 1217389 is a potent， and selective inhibitor of the monopolar spindle 1 (MPS1) kinase with an IC50 value less than 10 nM.[1-2] |
| In Vitro | BAY 1217389 inhibits Mps1 kinase activity with IC50 value below 10 nM while showing an excellent selectivity profile. In cellular mechanistic assays BAY 1217389 abrogates nocodazole-induced SAC activity and induces premature exit from mitosis resulting in multinuclearity and tumor cell death. BAY 1217389 efficiently inhibits tumor cell proliferation in vitro[1]. |
| 细胞实验 | BAY 1217389 achieves moderate efficacy in monotherapy in tumor xenograft studies. However， in line with its unique mode of action， when combines with paclitaxel， low doses of Mps1 inhibitor reduces paclitaxel-induced mitotic arrest in line with weakening of SAC activity. As a result， combination therapy strongly improves efficacy over paclitaxel or Mps1 inhibitor monotreatment at the respective MTDs in a broad range of xenograft models including those showing acquired or intrinsic paclitaxel-resistance. BAY 1217389 shows good tolerability without adding toxicity to paclitaxel monotherapy[1]. |
| 细胞实验 | Cells are seeded into 96 well plates at densities ranging from 1，000 to 5，000 cells per well in the appropriate medium supplemented with 10% FCS. After 24 hours， cells are treated in quadruplicates with serial dilutions of BAY 1161909 or BAY 1217389. After further 96 hours， adherent cells are fixed with glutaraldehyde and stained with crystal violet. IC50 values are calculated by means of a 4 parameter fit[1]. |
| 动物实验 | Mice: For tumor xenograft studies female athymic NMRI nu/nu mice， 50 days old， average body weight 20-22 g， are used. When tumors reaches a size of approximately 20-40 mm2， depending on growth of the tumor model， animals are randomized to treatment and control groups (8-10 mice / group) and treated p.o. with vehicle (70% polyethylene glycol 400， 5% Ethanol， 25% Solutol)， BAY 1161909， BAY 1217389， and/or paclitaxel. For analysis of polyploidy and multinuclearity induction in vivo， A2780cis tumor bearing female NMRI nude mice are treated with paclitaxel (i.v. once with 24 mg/kg)， BAY 1161909 p.o.twice daily for 2 days with 2.5 mg/kg and in combination with paclitaxel (i.v. once 24 mg/kg) and BAY 1161909 (p.o. twice daily for 2 days 1 mg/kg)[1]. |
| 激酶实验 | Inhibition of recombinant human Mps1 by BAY 1161909 or BAY 1217389 is assessed in TRFRET-based in vitro kinase assays via phosphorylation of a biotinylated peptide (Biotin-Ahx-PWDPDDADITEILG-NH2). Under standard assay conditions kinase and test compound are preincubated for 15 min before enzyme reaction is started by addition of substrate and ATP upon 10 μM[1]. |
| 数据来源文献 | [1]. Wengner AM， et al. Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity. Mol Cancer Ther. 2016 Apr;15(4):583-92.. . . . [2]. Wengner AM， et al. Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity. Mol Cancer Ther. 2016 Apr;15(4):583-92. |
| 单位 | 瓶 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
基因调控，但却有相关性。可能永生性是细胞恶变的阶段。至少在体外是如此。 （四）浸润性 浸润性是肿瘤细胞扩张性增殖行为，培养癌细胞仍持有这种性状。在与正常组织混合培养时，能浸润入其它组织细胞中，并有穿透人工隔膜生长的能力。 (T:] L(T4I tr \ （五）异质性 分学, 论坛, 化学分析, 仪器分析, 分析测试, 色谱, 电泳, 光谱:a ib m r {[1] D m T"k 所有肿瘤都是由有增殖
技术资料暂无技术资料 索取技术资料
IB2300 BAY-1217389 细胞周期 索莱宝
￥593 - 3840
